Market Newsdesk

LOS ANGELES, April 2, 2021 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Frequency Therapeutics, Inc. (“Frequency” or “the Company”) (NASDAQ: FREQ) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Frequency issued a press release on March 23, 2021, announcing topline data from its FX-322 Phase 2a study (FX-322-202). The Company admitted that “the interim results show that four weekly injections in subjects with mild to moderately severe sensorineural hearing loss (SNHL) did not demonstrate improvements in hearing measures versus placebo.” Based on this news, shares of Frequency dropped by almost 78% on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:
The Schall Law Firm 
Brian Schall, Esq. 
310-301-3335
[email protected] 
www.schallfirm.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/ongoing-investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-frequency-therapeutics-inc-and-encourages-investors-with-losses-of-100-000-to-contact-the-firm-301261461.html

SOURCE The Schall Law Firm

LOS ANGELES, April 2, 2021 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ubiquiti Inc. (“Ubiquiti” or “the Company”) (NYSE: UI) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Ubiquiti is the subject of an article posted by Krebs on Security on March 30, 2021. The article, titled “Whistleblower: Ubiquiti Breach ‘Catastrophic,'” alleges that “now a source who participated in the response to that breach alleges Ubiquiti massively downplayed a ‘catastrophic’ incident to minimize the hit to its stock price, and that the third-party cloud provider claim was a fabrication.” The article quotes a letter from the source to the European Data Protection Supervisor stating: “it was catastrophically worse than reported, and legal silenced and overruled efforts to decisively protect customers” and “the breach was massive, customer data was at risk, access to customers’ devices deployed in corporations and homes around the world was at risk.” Based on this news, shares of Ubiquiti fell by more than 7% on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:
The Schall Law Firm 
Brian Schall, Esq. 
310-301-3335
[email protected] 
www.schallfirm.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/ongoing-investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-ubiquiti-inc-and-encourages-investors-with-losses-of-100-000-to-contact-the-firm-301261449.html

SOURCE The Schall Law Firm

LOS ANGELES, April 2, 2021 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Neptune Wellness Solutions Inc. (“Neptune” or “the Company”) (NASDAQ: NEPT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between July 24, 2019 and February 16, 2021, inclusive (the ”Class Period”), are encouraged to contact the firm before May 17, 2021. 

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Neptune suffered from higher costs to integrate the assets of and operations of its SugarLeaf acquisition than it acknowledged, placing a considerable strain on the Company’s capital reserves. It was reasonably foreseeable that the Company would need to raise additional capital through additional stock offerings. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Neptune, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/investor-action-notice-the-schall-law-firm-reminds-investors-of-a-class-action-lawsuit-against-neptune-wellness-solutions-inc-and-encourages-investors-with-losses-in-excess-of-100-000-to-contact-the-firm-301261459.html

SOURCE The Schall Law Firm

LOS ANGELES, April 2, 2021 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BELLUS Health Inc. (“BELLUS” or “the Company”) (NASDAQ: BLU) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between September 5, 2019 and July 5, 2020, inclusive (the ”Class Period”), are encouraged to contact the firm before May 17, 2021.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. BELLUS misrepresented and/or failed to disclose that BLU-5937’s “high selectivity” contributed to the drug potentially being less efficacious and thus likely unable to meet the primary endpoint of the Company’s Phase 2 study. As a result, when Defendants announced before markets opened on July 6, 2020, that BLU-5937 had failed the Phase 2 study, the Company’s stock price plummeted over 75% on heavy trading volume. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about BELLUS, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com 
Office: 310-301-3335
[email protected]

View original content to download multimedia:http://www.prnewswire.com/news-releases/investor-action-notice-the-schall-law-firm-reminds-investors-of-class-action-lawsuit-against-bellus-health-inc-and-encourages-investors-with-losses-in-excess-of-100-000-to-contact-the-firm-301261454.html

SOURCE The Schall Law Firm

LOS ANGELES, April 2, 2021 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sequential Brands Group, Inc. (“Sequential Brands” or “the Company”) (NASDAQ: SQBG) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between November 3, 2016 and December 11, 2020, inclusive (the ”Class Period”), are encouraged to contact the firm before May 17, 2021.  

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Sequential Brands knew or should have known in late 2016 that its goodwill was impaired. The Company used every tactic possible to delay the material write down in goodwill starting in late 2016 and into 2017. The Company materially understated its operating expenses and net loss while simultaneously overstating its income from operations, goodwill, and assets during this period. The Company failed to maintain internal controls. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Sequential Brands, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com 
Office: 310-301-3335
[email protected]

View original content to download multimedia:http://www.prnewswire.com/news-releases/investor-action-alert-the-schall-law-firm-reminds-investors-of-a-class-action-lawsuit-against-sequential-brands-group-inc-and-encourages-investors-with-losses-in-excess-of-100-000-to-contact-the-firm-301261451.html

SOURCE The Schall Law Firm

RADNOR, Pa., April 2, 2021 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP reminds AgEagle Aerial Systems, Inc. (NYSE:  UAVS) (“AgEagle”) investors that a securities fraud class action lawsuit filed on behalf of those who purchased or acquired AgEagle securities between September 3, 2019 and February 18, 2021, inclusive (the “Class Period”).

Investor Deadline Reminder:  Investors who purchased or acquired AgEagle securities


during the Class Period may, no later than April 27, 2021, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP:  James Maro, Esq. (484) 270-1453 or Adrienne Bell, Esq. (484) 270-1435; toll free at (844) 887-9500; via e-mail at

[email protected]; orclick https://www.ktmc.com/ageagle-aerial-systems-class-action-lawsuit?utm_source=PR&utm_medium=link&utm_campaign=eagle 

AgEagle is a commercial drone company that is engaged in the design, engineering, and manufacturing of commercial drones, as well as in providing drone services and solutions to the agriculture industry.

The Class Period commences on September 3, 2019, when AgEagle issued a press release entitled: “AgEagle Enters the Fast-Growing Commercial Drone Package Delivery Market.” The subtitle read: “Initial Purchase Orders Received and Testing Underway.”  The press release stated, in part, that AgEagle “received [its] first purchase orders to manufacture and assemble UAVs designed to meet the critical specifications for drones that are meant to carry goods in urban and suburban areas. [AgEagle] look[s] forward to providing greater detail in the near future on AgEagle’s plans to address the needs of this highly specialized new market and the specific role [it] expects to play in its ongoing development.”

Throughout the Class Period, AgEagle signaled to investors that AgEagle had partnered with Amazon.com, Inc. (“Amazon”) to manufacture and assemble drones for the delivery of consumer goods.

However, on October 14, 2020, news broke that Amazon did not have a partnership agreement with AgEagle, and in fact never did. The Wichita Business Journal published a story with the headline: “Exclusive: Who’s AgEagle’s big customer? We now know who it’s not.” The article reported that AgEagle was not partnering with Amazon.

Then, on February 18, 2021, Bonitas Research published a report revealing that AgEagle “was a pump & dump scheme orchestrated by . . . AgEagle founder and former chairman Bret Chilcott and other UAVS insiders to defraud US investors.”  The report stated that “an Amazon spokesperson disclosed to reporter Daniel McCoy of the Witchita Business Journal that Amazon specifically does not have any dealings with AgEagle whatsoever.” Following this news, shares of AgEagle fell $5.13, or 36.4%, to close at $8.96 on February 18, 2021.

The complaint alleges that, throughout the Class Period, the defendants made false and/or misleading statements and/or failed to disclose that: (1) AgEagle did not have a partnership with Amazon and in fact never had any relationship with Amazon; (2) rather than correct the public’s understanding about a partnership with Amazon, the defendants were actively contributing to the rumor that AgEagle had a partnership with Amazon; and (3) as a result, the defendants’ statements about AgEagle’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

AgEagle investors may, no later than April 27, 2021, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member.  A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.  In order to be appointed as a lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class.  Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world.  The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars).  The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com.

CONTACT:
Kessler Topaz Meltzer & Check, LLP
James Maro, Jr., Esq.
Adrienne Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087
(844) 887-9500 (toll free)
[email protected]

View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert–kessler-topaz-meltzer–check-llp-announces-securities-fraud-class-action-lawsuit-filed-against-ageagle-aerial-systems-inc-301261184.html

SOURCE Kessler Topaz Meltzer & Check, LLP

NEW YORK, April 2, 2021 /PRNewswire/ — Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders.  Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies:

• 
  Spring Valley Acquisition Corp. (
  
  
  NASDAQ:
  
  
  SV)
  

Spring Valley Acquisition Corp.  has agreed to merge with AeroFarms.  Under the proposed transaction, shareholders of Spring Valley will own approximately 14.7% of the combined company.

• 
  CM Life Sciences II Inc. (NASDAQ: CMII)
  

CM Life Sciences II  has agreed to merge with SomaLogic.  Under the proposed transaction, shareholders of CM Life will own just 14% of the combined company.

• 
  Premier Financial Bancorp, Inc. (NASDAQ: PFBI)
  

Premier Financial Bancorp has agreed to be acquired by Peoples Bancorp.  Under the proposed transaction, shareholders of Premier Financial will receive 0.58 shares of Peoples common stock per share.

• 
  Qell Acquisition Corp. (NASDAQ: QELL)
  

Qell Acquisition Corp. has agreed to merge with Lilium GmbH.  Under the proposed transaction, shareholders of Qell will own only 11% of the combined company.

Moore Kuehn is investigating whether the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process. 

Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq. by email at [email protected] or telephone at (212) 709-8245.  The consultation and case are free with no obligation to you.  Moore Kuehn pays all case costs and does not charge its investor clients.Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

Moore Kuehn is a 5-star Google rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims.  For additional information about Moore Kuehn, please visit http://www.moorekuehn.com/practice/new-york-securities-litigation/.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8^th Floor
New York, New York 10005
[email protected] 
(212) 709-8245

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/moore-kuehn-encourages-sv-cmii-pfbi-and-qell-investors-to-contact-law-firm-301261445.html

SOURCE Moore Kuehn, PLLC